|
Exclusive nuclear FIH-1 expression (n = 42)
|
Nuclear and cytoplasmic FIH-1 expression (n = 143)
|
Exclusive cytoplasmic FIH-1 expression (n = 54)
|
Nuclear and cytoplasmic FIH-1-negative (n = 56)
|
---|
Median patient age (years)
|
57
|
56
|
58
|
56
|
Median tumour size (mm)
|
18
|
20
|
25
|
20
|
Tumour grade
| | | | |
1
|
12
|
24
|
3
|
8
|
2
|
12
|
43
|
17
|
15
|
3
|
8
|
35
|
21
|
12
|
Nodal status
| | | | |
Negative
|
23
|
77
|
32
|
35
|
Positive
|
19
|
64
|
22
|
20
|
Oestrogen receptor status
| | | | |
Negative
|
8
|
30
|
14
|
20
|
Positive
|
34
|
113
|
40
|
35
|
Human epidermal growth factor receptor 2 status
| | | | |
Negative
|
25
|
95
|
43
|
23
|
Positive
|
3
|
17
|
6
|
2
|
Hypoxia-inducible factor 1α
| | | | |
Negative
|
10
|
41
|
25
|
22
|
Positive
|
32
|
82
|
28
|
20
|
Carbonic anhydrase 9
| | | | |
Negative
|
34
|
111
|
33
|
22
|
Positive
|
3
|
14
|
11
|
4
|
Recurrence
| | | | |
Negative
|
32
|
88
|
28
|
37
|
Positive
|
9
|
54
|
26
|
18
|
- n < 295 data not available.